Product NDC: | 0409-7391 |
Proprietary Name: | Sodium Phosphates |
Non Proprietary Name: | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE and SODIUM PHOSPHATE, DIBASIC ANHYDROUS |
Active Ingredient(s): | 142; 276 mg/mL; mg/mL & nbsp; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE and SODIUM PHOSPHATE, DIBASIC ANHYDROUS |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-7391 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018892 |
Marketing Category: | NDA |
Start Marketing Date: | 20110831 |
Package NDC: | 0409-7391-72 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-7391-72) > 15 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0409-7391-72 |
Proprietary Name | Sodium Phosphates |
Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-7391-72) > 15 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0409-7391 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE and SODIUM PHOSPHATE, DIBASIC ANHYDROUS |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110831 |
Marketing Category Name | NDA |
Labeler Name | Hospira, Inc. |
Substance Name | SODIUM PHOSPHATE, DIBASIC ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
Strength Number | 142; 276 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes |